EarlySense, a patient care device maker, has received FDA clearance for its bedside system and central display with oximetry integration, according to AZ Sensors. The system is a continuous patient ...

Covidien has announced it has received FDA clearance and CE Mark approval for its bedside respiratory patient monitoring system, according to a news release. The company says the Nellcor system is ...

Waltham-based EarlySense Inc. said today it has received U.S. Food and Drug Administration clearance for an updated version of its bedside system that monitors and documents vital signs in patients.

EarlySense Inc., an Israeli company with US headquarters in Waltham, said Wednesday that it has received FDA clearance for an upgrade to its bedside system that monitors patients in hospitals and ...

<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...

DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

OptiScan Medical picked up a CE mark for its automated bedside monitoring device for the intensive care unit. The company plans to launch the device, which tracks blood glucose and lactate near ...

EarlySense, a patient care device maker, has received FDA clearance for its bedside system and central display with oximetry integration, according to AZ Sensors. The system is a continuous patient ...

The Food and Drug Adminstration on Wednesday granted market clearance to OptiScan Biomedical Corp.’s OptiScanner 5000 Glucose Monitoring System for use in the surgical intensive care unit. Here are ...

Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...